scholarly journals Relationship Of Glycated Haemoglobin (Hba1c) And Glucose In Streptozotocininduced Wistar Rats Is Determined By Linear Regression

2013 ◽  
Vol 3 (3) ◽  
pp. 1-5
Author(s):  
George Gborienemi Simeon ◽  
AA Uwakwe ◽  
GO Ibeh
Keyword(s):  
Diabetes Mellitus ◽  
Plasma Glucose ◽  
High Performance ◽  
Glycated Hemoglobin ◽  
Medical Science ◽  
Glycated Haemoglobin ◽  
Citrate Buffer ◽  
Liquid Chromatograph ◽  
Mean Values ◽  
Relationship Of

Objective To evaluate the relationship of glucose and glycated haemoglobin (HbA1C) in type 1 diabetes model induced by streptozotocin. Research Design and Methods Induction of diabetes mellitus was achieved through the intraperitoneal injection of 70mg/kg body weight of streptozotocin dissolved in 1m citrate buffer pH 4.5 twice daily for 2 days. A total number of thirty rats were used selected among those that have exceeded glucose threshold (>10.0mmol/l) 2 weeks after streptozotocin induction. All rats weighed between 240-300g. Samples for fasting plasma glucose and glycated haemoglobin were collected at the tail vein. Glucose was determined by the glucose oxidase method and HbA1C was determined by High Performance Liquid Chromatograph (HPLCEsi/ ms) with uv detection. Data was analysed by one way and two way analysis of variance using SPSS version. Results Significant linear relationship was demonstrated between plasma glucose level and glycated haemoglobin which could be predictive of risk of developing diabetes. Control samples had values within reference range, glucose (3.5-6.5 mmol/l) and glycated hemoglobin (4.3-7%). However diabetic test rats elicited values that varied significantly with time. Test result confirms the fact that higher mean values of plasma glucose in diabetic (positive) controls were due to the effect of streptozotocin. Conclusion Plasma glucose and glycated hemoglobin show positively mutual relationship and can be used in early diagnosis of diabetes mellitus. Using correlation coefficient and regression enhances measurement of the strength of the bivariate association and is predictive. Asian Journal of Medical Science, Volume-3 No-3 (2012), Page 1-5 DOI: http://dx.doi.org/10.3126/ajms.v3i3.4816

CORRELATION OF SERUM MAGNESIUM LEVELS WITH FASTING PLASMA GLUCOSE IN TYPE 2 DIABETES MELLITUS

2021 ◽  
pp. 16-18
Author(s):  
Nishanth Kumar ◽  
Malathi R D ◽  
Ramadevi M
Keyword(s):  
Diabetes Mellitus ◽  
Plasma Glucose ◽  
Fasting Plasma Glucose ◽  
Serum Magnesium ◽  
Fasting Blood Glucose ◽  
Mean Value ◽  
Control Group ◽  
Mean Values ◽  
Fasting Plasma ◽  
Increased Risk

Background: Diabetes mellitus is a metabolic disorder of multifactorial origin characterized by hyperglycemia and disturbances of glucose , fat and protein metabolism. Hypomagnesemia is been associated with chronic and uncontrolled diabetes mellitus. Magnesium deciency in diabetes is known to be associated with increased risk of microvascular and macrovascular complications. The aim of this study is to estimate fasting plasma glucose and serum magnesium levels and to assess the correlation of hypomagnesemia with abnormal fasting plasma glucose values. Material and Methods: The study was done at Government Medical College, Nizamabad. 80 subjects were recruited out of whom 40 apparently normal persons were taken as control group and the second group of 40 patients with known history of diabetes. The fasting plasma glucose(FPG) was estimated by GOD-POD method and serum Magnesium(Mg) levels were estimated using the Chemchek Mg kit which is based on Xylidyl Blue with ACTS method. Results :The mean values of fasting plasma glucose was 87.1 mg/dL in non diabetics when compared to 159.4 mg/dL in diabetics while Serum magnesium levels in control subjects had a mean value of 2.19mg/dLand 1.8mg/dLin diabetics. The data was analysed and found to be statistically signicant with a negative correlation between plasma magnesium and fasting blood glucose. Conclusion: There is signicant hypomagnesaemia which correlates increased fasting plasma glucose values in diabetics when compared to non diabetics and therefore assessing the serum magnesium levels may help in reducing risk of complications.

scholarly journals Comparison of glycated haemoglobin and fasting blood glucose in the diagnosis of diabetes mellitus and pre-diabetes in a cohort of obese patients

2017 ◽  
Vol 103 (1) ◽  
pp. 39-43
Author(s):  
D M L Chan ◽  
M Murphy
Keyword(s):  
Diabetes Mellitus ◽  
Blood Glucose ◽  
Diagnostic Criteria ◽  
Plasma Glucose ◽  
Fasting Plasma Glucose ◽  
Glycated Haemoglobin ◽  
World Health ◽  
Expert Committee ◽  
Obese Patients ◽  
Fasting Plasma

AbstractBackgroundDiabetes mellitus (DM) has historically been diagnosed by measurement of blood glucose concentrations. More recently, the use of glycated haemoglobin (HbA1c) has been advocated in the diagnosis of diabetes, complementing its existing role in the monitoring of glycaemic control.A recent study has shown that obesity is an important problem in the UK Armed Forces. Obese patients are at increased risk of diabetes and intermediate hyperglycaemia (pre-diabetes). It is unclear whether the application of diagnostic criteria based on HbA1c would produce different categorisation of obese patients compared with standard glucose-based criteria. In the current study, we compared HbA1c with fasting plasma glucose in the diagnosis of type 2 diabetes and intermediate hyperglycaemia in a cohort of obese patients.MethodsPatients were recruited from the NHS Tayside Specialist Weight Management Service. They were classified into three categories (normoglycaemia, pre-diabetes, and diabetes) according to their fasting plasma glucose (FPG) and HbA1c. The diagnostic criteria of three organisations were applied: the World Health Organisation (WHO); the American Diabetes Association (ADA); and the International Expert Committee (IEC). Glucose, insulin, cholesterol, triglycerides, uric acid, liver function tests and sex hormone-binding globulin (SHBG) were measured.ResultsBy WHO (fasting glucose) criteria, 102 subjects were classified as normal, 13 as having impaired fasting glycaemia (IFG) and 5 as having diabetes mellitus (DM). By IEC (HbA1c) criteria, 89 subjects were classified as normal, 21 as pre-diabetes and 7 as DM. By ADA (HbA1c) criteria, 69 subjects were classified as normal, 41 as pre-diabetes and 7 as DM. Alkaline phosphatase was significantly higher in hyperglycaemic states compared with normal subjects, with ANOVA F statistics of 9.45 for WHO (p < 0.001), 9.24 for IEC (p < 0.001), and 6.87 for ADA (p < 0.01).ConclusionAlthough the numbers were small, more obese patients were categorised as hyperglycaemic (pre-diabetes and diabetes) when HbA1c-based criteria were applied, compared with WHO (glucose-based) criteria. Further studies are required to confirm this preliminary observation.

scholarly journals International guidelines on the study of glycated hemoglobin HbA1c level as a diagnostic criterion for diabetes mellitus and otherdisorders of carbohydrate metabolism

2010 ◽  
Vol 13 (4) ◽  
pp. 57-61
Author(s):  
Gagik Radikovich Galstyan
Keyword(s):  
Diabetes Mellitus ◽  
High Frequency ◽  
High Performance ◽  
Metabolic Disorders ◽  
Glycated Hemoglobin ◽  
Vascular Complications ◽  
Cost Effective ◽  
The World ◽  
Diagnostic Criterion

Type 2 diabetes mellitus is rising at an epidemic scale throughout the world. Up to a certain moment, DM2 develops as a latent pathology which accounts for its late diagnosis and onset of therapy. Hence, the high frequency of vascular complications, early disablement and mortality. Therefore, the improvement of screening studies is of primary importance for the detection of metabolic disorders. At present, HbA1c determination is the most informative and cost-effective tool for the purpose. The choice of the method for measuring HbA1c is a paramount consideration. It must be standardized against a reference technique (high performance liquid chromatography) in conformity with the results of DCCT and UKPDS studies

High Performance Liquid Chromatographic Determination of Minor Saccharides in Corn Sugar: Collaborative Study

1982 ◽  
Vol 65 (6) ◽  
pp. 1366-1369
Author(s):  
C Earl Engel ◽  
Philip M Olinger ◽  
Raffaele Bernetti ◽  
◽  
K M Brobst ◽  
...  
Keyword(s):  
High Performance ◽  
Collaborative Study ◽  
Chromatographic Determination ◽  
High Performance Liquid Chromatographic ◽  
Liquid Chromatograph ◽  
Mean Values ◽  
Water Solvent ◽  
Coefficients Of Variation ◽  
Aoac Method

Abstract The official first action AOAC method for quantitative determination of saccharides in corn syrup by liquid chromatography was reinvestigated to expand its scope to products containing dextrose in excess of 98%. Because of the low levels of saccharides other than dextrose (DP1), separations are carried out only of the DP1, the disaccharides (DP2), and the tri- and higher saccharides (DP3+) on an Aminex Q15-S, calcium form, cation exchange column. Concentrations of solids in water solvent injected into the liquid chromatograph are higher than those in the AOAC method to increase precision of analysis of the minor saccharides. All carbohydrate components in solution are eluted from the column; therefore, loss of refractive index detector linearity with respect to dextrose is compensated by use of an external maltose (DP2) standard to correct for DP2 and DP3+ response and dextrose is calculated by difference from 100. With mean values of 0.520% DP2 and 0.244% DP3+, the reproducibility and repeatability coefficients of variation are 14.6 and 6.7% for DP2, and 19.3 and 11.9% for DP3+, respectively. Dextrose levels of 99.23% are reproducible within 0.161. The coefficients of variation of the DP2 component are lower by this method than by the AOAC method at levels up to 2% DP2. The method has been adopted official first action.

scholarly journals Characterization of condensed tannins from native legumes of the Brazilian northeastern semi-arid

2006 ◽  
Vol 63 (6) ◽  
pp. 522-528 ◽  
Author(s):  
Patrícia Mendes Guimarães-Beelen ◽  
Telma Teresinha Berchielli ◽  
Roger Beelen ◽  
João Araújo Filho ◽  
Simone Gisele de Oliveira
Keyword(s):  
Condensed Tannins ◽  
High Performance ◽  
Diffusion Method ◽  
Liquid Chromatograph ◽  
Caatinga Vegetation ◽  
Monomeric Composition ◽  
Tannin Concentration ◽  
Phenological Cycle ◽  
Relationship Of ◽  
Ruminal Digestion

Despite the possible influence of tannins on the nutritional value of the forages from Caatinga vegetation, there are few studies that evaluated their tannin concentration. This study was conducted to characterize condensed tannins present in the legumes species Mimosa hostilis (Jurema Preta), Mimosa caesalpinifolia (Sabiá) and Bauhinia cheilantha (Mororó), at three stages of their phenological cycle. The concentration of soluble tannin (ST), bound tannin (BT) and total tannin (TT) were determined using the butanol-HCL method; astringency was by the radial diffusion method, and the monomeric composition of purified tannins by a high-performance liquid chromatograph with delphinidin, cyanidin and pelargonidin as standards. Concentration and astringency of purified condensed tannins, as well as their monomeric composition varied between species, and in some cases among phenological cycles. The values observed were always above the limits considered beneficial for ruminal digestion (i.e. 5%). Jurema Preta presented the highest values (30.98% TT and 22% astringency at full growth stage), and Mororó the lowest (10.38% TT and 14% astringency during fructification). Jurema Preta presented a mean relationship prodelfinidin (PD): procyanidin (PC) of 97:3, which did not vary during the phenological cycle, showing the high astringent capacity of these tannins. Sabiá presented a relationship of 90:20 during full growth and flowering stages, decreasing to 40:50 at fructification. In Mororó the PD:PC relationship was more equilibrated, around 40:50 during full growth and flowering stages, decreasing to 35:60 During fructification. Propelargonidin was not detected or was present at low concentration in the three species.

scholarly journals Beneficial effects of valencene on altered glycoprotein components in streptozotocin-nicotinamide induced diabetic rats

2019 ◽  
Vol 9 (4-A) ◽  
pp. 191-196
Author(s):  
Ellappan Pari ◽  
Pari Leelavinothan ◽  
Thangasamy Gunaseelan ◽  
Duraisamy Kannan
Keyword(s):  
Diabetes Mellitus ◽  
Plasma Glucose ◽  
Plasma Insulin ◽  
Experimental Diabetes ◽  
Insulin Level ◽  
Diabetic Rats ◽  
Glycemic Status ◽  
Experimental Diabetes Mellitus ◽  
Citrate Buffer ◽  
Beneficial Effects

ABSTRACT Objective: To investigate the effect of valencene on dearrangement in glycoprotein levels in the streptozotocin(STZ)-nicotinamide(NA)induced diabetic rats. Materials and Methods: Diabetes was induced in experimental rats by a single intraperitoneal (i.p) injection of STZ (45 mg/kg b.w) dissolved in 0.1 M citrate buffer (pH 4.5) 15 minutes after the i.p injection of NA (110 mg/kg b.w). The levels of glycoproteins were altered in experimental diabetes mellitus. Valencene were administered to diabetic rats intragastrically at 100 & 200mg/kg bw for 30days. The effects of valencene on plasma glucose, insulin, plasma and tissue glycoproteins were studied. Results: Oral administration of valencene (200mg/kg b.w)for 30d, dose dependently improved the glycemic status in STZ-NA induced diabetic rats. The levels of plasma glucose were decreased with significant increase of plasma insulin level. The altered levels of plasma and tissue glycoprotein components were restored to near normal. Conclusions: The results of the present study show the potent beneficial effects of valencene in modifying the levels of glycoprotein components in plasma and tissues of diabetic rats.

scholarly journals Altered levels of fructosamine and glycated haemoglobin (HbA1c) in thyroid disorder patients without diabetes mellitus-A cross sectional study

Biomedicine ◽  
2021 ◽  
Vol 41 (1) ◽  
pp. 46-51
Author(s):  
G.Sajjan Sangamma ◽  
S. Sonoli Smita ◽  
Naveen Angadi
Keyword(s):  
Diabetes Mellitus ◽  
Plasma Glucose ◽  
Fasting Plasma Glucose ◽  
Glycated Hemoglobin ◽  
Thyroid Disorder ◽  
Newly Diagnosed ◽  
Fasting Plasma ◽  
Significant Difference ◽  
The Mean ◽  
Hba1c Levels

Introduction and Aim:Co-existence of thyroid disorder and Diabetes Mellitus is no more a coincidence. The cause and impact of thyroid disorder on glucose levels or vice versa is a well -established fact.Hence in this study we wanted to know the glycemic status by estimating fructosamine and glycated hemoglobin of the newly diagnosed thyroid patients without diabetes mellitus. The aim of the study was to estimatefructosamine and glycated hemoglobin levels in newly diagnosed subclinical hypothyroid, clinical hypothyroid and hyper thyroid patients without diabetes mellitus. Material and Methods:Twenty cases of subclinical hypothyroid,30 cases of hypothyroid,30 cases of hyperthyroid  and 30 healthy participantswere included in the study. Fasting plasma glucose and thyroid profile was estimated in suspected cases of thyroid disorder and participants with fasting plasma glucose (FPG) more than 110 mg/dL were excluded from the study.The participants who were eligible for an inclusion criterion were estimated for fructosamine by nitro bluetetrazolium, (NBT) method andion-exchange high performance liquid chromatography was for glycated hemoglobin. Results:In Subclinical hypothyroid group there was a statistically significant increase in the mean fasting plasma glucose, fructosamine and glycated hemoglobin levels when compared with the controls.There was a significant increase in the mean fasting plasma glucose,fructosamine and glycated hemoglobin(HbA1c) levels in clinical hypothyroid group when compared with the controls.Pairwise comparison of FPG (p=0.001), fructosamine (p=0.001) and HbA1c (p=0.001) levels with controls showed a statistically significant difference.In clinical hyperthyroid group the mean FPG and HbA1c levels were high and low fructosamine levels when compared with the controls by one way ANOVA.Pairwise comparison of FPG (p=0.001), fructosamine levels (p=0.001) and HbA1c (p=0.001) levels (p=0.001) with controls showed a statistically significant difference. Conclusion: Unidentified hyperglycemia could have an impact on thyroid disorder leading to its complication.Hence a systematic approach to fructosamine testing(monitor the plasma glucose concentration over 2–3 weeks) as a routine test in thyroid disorder patients, needs to be considered.Also the management of hyperglycemia in thyroid patients without diabetes mellitus may prove  to be beneficial.  

Sign in / Sign up

Export Citation Format

Share Document